{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:29:03Z","timestamp":1774949343435,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"am","delay-in-days":334,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.annder.2024.103301","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T16:42:37Z","timestamp":1722530557000},"page":"103301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mucocutaneous manifestations of inflammatory bowel disease"],"prefix":"10.1016","volume":"151","author":[{"given":"F.","family":"Amatore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-F.","family":"Colombel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Delaporte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2024.103301_b0005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MPG.0b013e3181ca4db4","article-title":"Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity","volume":"51","author":"Dotson","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.annder.2024.103301_b0010","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3390\/jcm10020364","article-title":"Dermatological manifestations in inflammatory bowel diseases","volume":"10","author":"Antonelli","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.annder.2024.103301_b0015","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn\u2019s disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.annder.2024.103301_b0020","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"Kostic","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.annder.2024.103301_b0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1462-5822.2009.01381.x","article-title":"Crohn\u2019s disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly","volume":"12","author":"Lapaquette","year":"2010","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.annder.2024.103301_b0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00384-023-04354-4","article-title":"Fecal microbiota transplantation for induction of remission in Crohn\u2019s disease: a systematic review and meta-analysis","volume":"38","author":"Zhou","year":"2023","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.annder.2024.103301_b0035","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1038\/s41467-021-22164-6","article-title":"Single-cell analyses of Crohn\u2019s disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions","volume":"12","author":"Jaeger","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.annder.2024.103301_b0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11882-015-0562-9","article-title":"Immune responses to intestinal microbes in inflammatory bowel diseases","volume":"15","author":"Hansen","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.annder.2024.103301_b0045","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.14309\/ajg.0000000000001396","article-title":"A comprehensive literature review and expert consensus statement on therapeutic drug monitoring of biologics in inflammatory bowel disease","volume":"116","author":"Cheifetz","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.annder.2024.103301_b0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/ecco-jcc\/jjx143","article-title":"Vedolizumab in IBD-lessons from real-world experience; a systematic review and pooled analysis","volume":"12","author":"Engel","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.annder.2024.103301_b0055","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nri1784","article-title":"Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease","volume":"6","author":"Adams","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.annder.2024.103301_b0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/07853890903559724","article-title":"Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management","volume":"42","author":"Larsen","year":"2010","journal-title":"Ann Med"},{"key":"10.1016\/j.annder.2024.103301_b0065","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/11310730-000000000-00000","article-title":"Neutrophilic dermatoses: a review of current treatment options","volume":"10","author":"Cohen","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.annder.2024.103301_b0070","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1007\/s10620-013-2762-2","article-title":"Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease","volume":"58","author":"Arg\u00fcelles-Arias","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.annder.2024.103301_b0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/1744666X.2018.1438269","article-title":"Pyoderma gangrenosum: a review of pathogenesis and treatment","volume":"14","author":"Ahn","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.annder.2024.103301_b0080","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/1346-8138.16504","article-title":"Clinical characteristics of peristomal pyoderma gangrenosum: a single center retrospective observational study","volume":"49","author":"Honma","year":"2022","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2024.103301_b0085","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/DCR.0000000000001701","article-title":"The management of peristomal pyoderma gangrenosum in IBD","volume":"63","author":"O\u2019Brien","year":"2020","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.annder.2024.103301_b0090","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/ecco-jcc\/jjab079","article-title":"Systematic review: sweet syndrome associated with inflammatory bowel disease","volume":"15","author":"Sleiman","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.annder.2024.103301_b0095","first-page":"4556250","article-title":"Enthesitis in Bowel-associated dermatosis-arthritis syndrome in an ulcerative colitis patient","volume":"2022","author":"Alshahrani","year":"2022","journal-title":"Case Rep Rheumatol"},{"key":"10.1016\/j.annder.2024.103301_b0100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/ajd.13516","article-title":"Bowel-associated dermatosis-arthritis syndrome [BADAS]","volume":"62","author":"Richarz","year":"2021","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.annder.2024.103301_b0105","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1600-0714.2012.01152.x","article-title":"Pyostomatitis vegetans and its relation to inflammatory bowel disease, pyoderma gangrenosum, pyodermatitis vegetans, and pemphigus","volume":"41","author":"Nico","year":"2012","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.annder.2024.103301_b0110","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.revmed.2011.02.001","article-title":"Aseptic abscesses syndrome","volume":"32","author":"Andr\u00e9","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.annder.2024.103301_b0115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.semarthrit.2015.07.006","article-title":"Vasculitis in patients with inflammatory bowel diseases: a study of 32 patients and systematic review of the literature","volume":"45","author":"Sy","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.annder.2024.103301_b0120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12328-020-01280-8","article-title":"IgA vasculitis in a patient with ulcerative colitis under infliximab: drug-induced or genetic?","volume":"14","author":"Urushikubo","year":"2021","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.annder.2024.103301_b0125","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/jamadermatol.2019.0891","article-title":"Association of hidradenitis suppurativa with inflammatory Bowel disease: a systematic review and meta-analysis","volume":"155","author":"Chen","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.annder.2024.103301_b0130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/MIB.0000000000000579","article-title":"Identification of clinical and genetic parameters associated with hidradenitis suppurativa in inflammatory Bowel disease","volume":"22","author":"Janse","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.annder.2024.103301_b0135","doi-asserted-by":"crossref","first-page":"1151370","DOI":"10.3389\/fmed.2023.1151370","article-title":"Hidradenitis suppurativa: coexistence or dermatological extraintestinal manifestation of Crohn's disease?","volume":"10","author":"Luporini","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.annder.2024.103301_b0140","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jid.2021.05.036","article-title":"Altered skin and gut microbiome in hidradenitis suppurativa","volume":"142","author":"McCarthy","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2024.103301_b0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","article-title":"3rd European evidence-based consensus on the diagnosis and management of Crohn\u2019s Disease 2016: Part 1: diagnosis and medical management","volume":"11","author":"Gomoll\u00f3n","year":"2017","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.annder.2024.103301_b0150","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cgh.2015.04.180","article-title":"Features of patients with Crohn\u2019s disease and hidradenitis suppurativa","volume":"14","author":"Kamal","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.annder.2024.103301_b0155","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/ecco-jcc\/jjv037","article-title":"Vulval Crohn\u2019s disease: a clinical study of 22 patients","volume":"9","author":"Laftah","year":"2015","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.annder.2024.103301_b0160","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/pde.12772","article-title":"Penile and scrotal swelling: an underrecognized presentation of Crohn\u2019s disease","volume":"33","author":"Barrick","year":"2016","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.annder.2024.103301_b0165","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/apt.13217","article-title":"Review article: non-malignant oral manifestations in inflammatory bowel diseases","volume":"42","author":"Katsanos","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.annder.2024.103301_b0170","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/ibd.21599","article-title":"Distinguishing orofacial granulomatosis from crohn\u2019s disease: two separate disease entities?","volume":"17","author":"Campbell","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.annder.2024.103301_b0175","first-page":"e17191","article-title":"Mucocutaneous manifestations of inflammatory bowel disease","volume":"13","author":"Alvarez-Payares","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.annder.2024.103301_b0180","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1601-0825.2012.01918.x","article-title":"Biologics in oral medicine: oral Crohn\u2019s disease and orofacial granulomatosis","volume":"18","author":"O\u2019Neill","year":"2012","journal-title":"Oral Dis"},{"key":"10.1016\/j.annder.2024.103301_b0185","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/MOP.0000000000000652","article-title":"Cutaneous manifestations of nutritional deficiency","volume":"30","author":"Lekwuttikarn","year":"2018","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.annder.2024.103301_b0190","first-page":"21","article-title":"Management of cutaneous disorders related to inflammatory bowel disease","volume":"25","author":"Pellicer","year":"2012","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.annder.2024.103301_b0195","first-page":"225","article-title":"Dermatologic manifestations of inflammatory bowel disease: a review","volume":"25","author":"Keyal","year":"2018","journal-title":"Discov Med"},{"key":"10.1016\/j.annder.2024.103301_b0200","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.gtc.2017.08.011","article-title":"Vitamins and minerals in inflammatory bowel disease","volume":"46","author":"Ghishan","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.annder.2024.103301_b0205","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.3748\/wjg.v28.i33.4834","article-title":"Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease","volume":"28","author":"Gordon","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.annder.2024.103301_b0210","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/nu9040382","article-title":"Associations between folate and vitamin B12 levels and inflammatory bowel disease: a meta-analysis","volume":"9","author":"Pan","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.annder.2024.103301_b0215","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3390\/nu15081991","article-title":"Nutritional status and its detection in patients with inflammatory bowel diseases","volume":"15","author":"Jab\u0142o\u0144ska","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.annder.2024.103301_b0220","article-title":"Effectiveness of vitamin D supplementation on disease course in inflammatory bowel disease patients: systematic review with meta-analysis","author":"Valvano","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.annder.2024.103301_b0225","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/ibd\/izy025","article-title":"Management of Crohn\u2019s disease and complications in patients with ostomies","volume":"24","author":"Wang","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.annder.2024.103301_b0230","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/ced.12114","article-title":"Epidermolysis bullosa acquisita and inflammatory bowel disease: a review of the literature","volume":"38","author":"Reddy","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2024.103301_b0235","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/jamadermatol.2018.3631","article-title":"Association of psoriasis with inflammatory bowel disease: a systematic review and meta-analysis","volume":"154","author":"Fu","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.annder.2024.103301_b0240","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gutjnl-2012-302853","article-title":"Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-\u03b3-expressing Th1 cells and IL-17A\/IL-22-expressing Th17 cells and respond to anti-IL-12\/IL-23 antibody treatment","volume":"63","author":"Tillack","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.annder.2024.103301_b0245","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cgh.2010.07.022","article-title":"Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy","volume":"8","author":"Rahier","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.annder.2024.103301_b0250","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.autrev.2013.06.005","article-title":"Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-\u03b1 agents","volume":"13","author":"Fiorino","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.annder.2024.103301_b0255","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40257-017-0296-7","article-title":"Clinical signs, pathophysiology and management of cutaneous side effects of anti-tumor necrosis factor agents","volume":"18","author":"Segaert","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"Suppl 3","key":"10.1016\/j.annder.2024.103301_b0260","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.annder.2024.103301_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10067-015-3115-7","article-title":"Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses","volume":"35","author":"Chen","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.annder.2024.103301_b0270","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/ecco-jcc\/jjv122","article-title":"Oral cancer and oral precancerous lesions in inflammatory bowel diseases: a systematic review","volume":"9","author":"Katsanos","year":"2015","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.annder.2024.103301_b0275","first-page":"277","article-title":"Perceived oral health in patients with Crohn\u2019s disease","volume":"7","author":"Rikardsson","year":"2009","journal-title":"Oral Health Prev Dent"},{"key":"10.1016\/j.annder.2024.103301_b0280","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ibd\/izab056","article-title":"Tofacitinib for the treatment of ulcerative colitis: analysis of nonmelanoma skin cancer rates from the ulcerative colitis clinical program","volume":"28","author":"Sands","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.annder.2024.103301_b0285","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1056\/NEJMoa2212728","article-title":"Upadacitinib induction and maintenance therapy for Crohn's disease","volume":"388","author":"Loftus","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2024.103301_b0290","doi-asserted-by":"crossref","first-page":"e15688","DOI":"10.1111\/dth.15688","article-title":"Management of acne induced by JAK inhibitors","volume":"35","author":"Correia","year":"2022","journal-title":"Dermatol Ther"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963824000577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963824000577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T22:43:11Z","timestamp":1726785791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963824000577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0151963824000577"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2024.103301","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucocutaneous manifestations of inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2024.103301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103301"}}